Blog Archives

President’s Update – MassBio in 2015: A Year in Review

MassBio PresidentDear Readers,

As 2015 comes to a close and we prepare for an exciting 2016, I want to thank you for your involvement and support and reflect on 2015 with a Year in Review highlighting our biggest focus areas of 2015.

MassBio is committed to delivering maximum value to our 700+ member organizations by providing best-in-class programming, events, services and opportunities. Our goal is to support the needs of our members by helping extend capital, providing valuable business development opportunities and offering relevant, forward-thinking content.

foundersCelebrating 30 Years of Innovation

This year, we celebrated our 30th anniversary and looked back at 30 years of innovation as we welcomed MassBio’s founders to our Annual Meeting. As we look to the future, we are working with our members and stakeholders across the ecosystem to ensure that the Massachusetts’ life sciences supercluster continues to thrive and grow for the next 30 years – and beyond!

The Question of Value

Impact 2020, MassBio’s strategic report, called Massachusetts stakeholders across industry, academia, healthcare networks, payers and government to drive the conversation on defining value and reward for innovation in the era of outcomes-focused medicine.

This year, that goal became even more urgent as issues around drug pricing and the costs of healthcare hit mainstream media in Massachusetts and nationwide. MassBio has and will continue to convene stakeholders to discuss alignment on drug cost and pricing topics, through conversations and programming at our Policy Leadership Breakfast, Annual Meeting and Forum series on value.

We also continue to educate policy makers – through convening the Biotech Caucus, participating with the Health Policy Commission and serving on the Managed Care Organization Task Force – to ensure the work our member companies are doing is incentivized and rewarded in any evolving healthcare system. It is critical in Massachusetts and beyond that we preserve and foster innovation so patients can receive the cures they so desperately need.

A #PatientDriven Mission

alsIn 2015, the MassBio Board of Directors officially adopted our new mission statement: Advance Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives.

This new mission statement is meant to bring focus to the people at the heart of the work we all do: the patients. We work to bring that mission to life through programming like the second annual Patient Advocacy Summit, a sold-out event that brought industry leaders and patient advocates together to examine ways in which life sciences companies can more fully incorporate the patient voice into the work they do throughout the drug development cycle.

Print

We also hosted a series of Forums on how to harness the power of social media which included a session on leveraging social platforms for patient advocacy. We then invited our members to share how their work is patient driven through photos and videos on social media and hosted a Twitter Chat on the topic using the hashtag #PatientDriven.

We look forward to continuing this conversation in 2016.

Catalyzing Innovation

massconnectMassBio supports innovation at its earliest stages. This year we matched 12 startups with teams of mentors through the MassCONNECT program. It was a banner year for MassCONNECT graduates, who have made deals with biopharma partners, won international business plan competitions and reached product milestones. The program has also grown through official partnerships with a number of accelerators and incubators (including the prestigious OneStart Competition), value-add informational sessions for entrepreneurs like our recent National Institute of Neurological Disorders and Stroke program and entrepreneur bootcamps.

Through Pharma Days, our customized, invitation-only partnering events, we ensure pharma companies meet the right biotech and startup partners. We are constantly seeking partnerships and relationships to help early-stage life sciences companies meet their next milestones.

This year we convened thousands of members of the life sciences community at more than 100 events. We continue to rollout unique, targeted events that connect our members with shared interests, including biomanufacturing programming, life sciences information technology and big data programming, our new General Counsel Executive Group, new Nonprofit Leaders Roundtable and our annual CSO Roundtable.

Supporting Local Growth, Global Collaboration

groundbreakingIn 2015, MassBio welcomed a number of global companies as they opened new Massachusetts offices, including as Eli Lilly, GSK, and Bristol-Myers Squibb and more. This year we hosted visitors from 17 life sciences clusters around the world, ranging from Iceland, to France, to China.

MassBio also supports our local cities and towns across the Commonwealth as they grow their life sciences clusters and become BioReady® by adopting bio-friendly policies.

We will continue to partner with the new administration and the Massachusetts Life Science Center leadership to advocate for and develop the next iteration of the Life Sciences Initiative.

Boosting Your Bottom Line

In 2015, we expanded the MassBio Purchasing Consortium to include competitive pricing and best-in-class customer service from Industrial Protection Products, UniFirst Corporation and publications such as Science and Banker & Tradesman. Stay tuned for savings from new suppliers in 2016.Employee Perks Logo v3

This year we also expanded our Employee Rewards program, offering special savings and incentives at 30+ restaurants, retailers and attractions specifically for the employees of our member companies. In 2016 we will build out the program in key regions outside of Boston/Cambridge.

Preparing the Workforce of the Future

mdedAs we look toward the future, cultivating talent in Massachusetts will remain a priority. This year, Peter Abair, formerly MassBio’s Director of Economic Development & Global Affairs, became the new Executive Director of the MassBioEd Foundation. MassBio will continue to work closely with Peter and the MassBioEd Foundation to inspire students, engage teachers and guide the life sciences workforce of the future.

This year, MassBioEd began creating a job trends and forecasting tool, which will build upon MassBioEd’s educational programming by providing a clear understanding of what jobs are trending strongly, the skills that are associated with those positions and which job opportunities will be available in the future.

To enhance the careers of those already in the industry, MassBio organizes regular professional development and networking events. MassBio members can also access discounts on MassBioEd training courses.

Thank you for making our 30th year a great one. 2016 promises to be even busier and more productive.

Best wishes for a happy and healthy new year,
Bob Coughlin

Advertisements

President’s Update – MassBio in 2014: A Year in Review

MassBio PresidentDear Readers,

As 2014 comes to a close and we prepare for what’s coming in 2015, I want to thank you for your involvement and support and reflect on 2014 with a Year in Review highlighting our biggest focus areas of 2014.

1. Shaping the Future

This year, MassBio released Impact 2020, a strategic report on the state of the biotechnology and life sciences cluster in Massachusetts. Impact 2020 calls Massachusetts stakeholders across industry, academia, healthcare networks, payers and government to:impact

  • Drive the conversation on defining value and reward for innovation in the era of outcomes-focused medicine;
  • Seize a leadership opportunity at the intersection of tech and life sciences;
  • Evolve funding models for early-stage companies and innovative ideas;
  • Improve workforce development to ensure a workforce trained for the jobs of the future & support downstream expansion; and
  • Highlight patient stories to showcase the impact of innovation taking place in Massachusetts.

Impact 2020 will guide MassBio’s initiatives in the next five years, and MassBio has already started integrating the report into our programs and services.

2. Defining Value, Focusing on the Patient

defining valueMassBio joined the conversation on defining value at our Policy Leadership Breakfast in January, where a panel of experts discussed how medical innovation can exist in a new era of healthcare cost containment. We continued the discussion at the 2014 MassBio Annual Meeting and through the year with a Forum series called The Future of Biotech: Defining & Building Value in Healthcare.

No conversation on value would be complete without the patient voice, so in 2014 MassBio hosted its first ever Patient Advocacy Summit. The sold-out Summit brought industry leaders and patient advocates together to examine ways in which life sciences companies can more fully incorporate the patient voice into the work they do throughout the drug development cycle. MassBio will continue educate and support members as they seek to define and demonstrate the value of new treatments.

3. Catalyzing Innovation

catalyzing

MassBio supports innovation at its earliest stages. This year we matched 12 startups with teams of mentors through the MassCONNECT program. It was a banner year for MassCONNECT graduates, who have made deals with biopharma partners, won international business plan competitions and reached product milestones. We also continued to host Pharma Days, our customized, invitation-only partnering events designed to ensure pharma companies meet the right biotech and startup partners.

The findings of Impact 2020 and our annual Industry Snapshot demonstrate that early-stage funding is at a critical juncture. To start needed conversations on this, we hosted a Beg, Borrow & Crowdsource panel discussion at the Annual Meeting and three MassBio Twitter Chats (new in 2014!) on entrepreneurism, seed- and early-stage funding.

We continue to roll out unique, targeted events to convene our members with shared interests, including a new legal workshop in partnership with the American Bar Association, our annual CSO Roundtable, and a BIO Convention debrief.
Read the rest of this entry

President’s Update – MassBio in 2013: A Year in Review

MassBio President

Dear Readers,

As we start winding down 2013 and gear up for 2014, I want to thank you for your involvement and support and reflect on 2013 with a Year in Review highlighting our biggest focus areas of 2013.

1. Delivering Enhanced Programs

MassBio is committed to delivering maximum value to our member organizations by providing best-in-class programming, events, and opportunities. Our goal is to support the needs of our members by helping extend capital, providing valuable business development opportunities and offering relevant, unique, and forward-thinking content.

FORUMS logoThis year we launched MassBio Forums, our new and improved content and networking sessions designed to address the ever-changing needs of the diverse life sciences community. Content for our Forums was driven by the new Forum Advisory Board and Forum Working Groups comprised of 51 volunteers from our membership.

We continue to focus on bringing relevant content and speakers to our larger events as well. This year’s MassBio Annual Meeting featured keynotes from FDA Commissioner Margaret Hamburg and inspiring patient advocate John Crowley, Chairman & CEO of Amicus Therapeutics, Inc. We also brought the patient-focused programming of Lifecycle Massachusetts to BIO  in Chicago and once again hosted the productive partnering conference BioPharm America.

2. Boosting Your Bottom Line

Read the rest of this entry

President’s Update – MassBio in 2012: A Year in Review

MassBio President

 

Dear Readers,

As we start winding down 2012 and gear up for 2013, I want to thank you for your involvement and support and reflect on 2012 with a Year in Review highlighting our four biggest focus areas of 2012.

1. Bringing value to your bottom line

Here at MassBio we know that the battle to raise funding and keep costs down continues to be a challenge. That’s why we focused on bringing value to your bottom line in 2012, by expanding and improving our Purchasing Consortium. This year Fisher Scientific, Airgas, Linde, Alert, Stericycle, and W.B. Mason all expanded their services for MassBio members, allowing you to buy the goods and services you need at the best prices out there. We also announced two new partnerships this year to support our members: JoVE and Allsteel.

The Journal of Visualized Experiments (JoVE) is a peer reviewed, PubMed indexed journal devoted to the publication of research in a cutting-edge video format. With our new Allsteel Inc partnership, MassBio members access high-quality furniture at a discount. As MassBio prepared for our office relocation in the beginning of 2012 we were immediately impressed by the quality of products and service that Allsteel had to offer.

Also in 2012, we put together a Small Business Program with additional savings and start-up programs from our suppliers designed specifically for our member companies with fewer than 50 employees. In 2013, we will continue to negotiate steep discounts on the products and services you need, so you can invest resources where they matter, into the research required to drive new treatments and cures.

2. Advocating for you on Beacon Hill & Capitol Hill

Read the rest of this entry